Literature DB >> 19442462

High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro.

Yuan Shen1, Hui Peng, Jingjing Deng, Yuting Wen, Xin Luo, Shirong Pan, Chuanbin Wu, Min Feng.   

Abstract

The relatively low efficiency of transgene expression is a major drawback of non-viral gene delivery systems despite it being a safer alternative for gene therapy. Modifications of non-viral carriers with peptides have been utilized to improve their gene transfer efficiency. In this study, we described a new combined carrier, which was comprised of a cationic polymer, polyethylenimine (PEI), and a nuclear protein, high mobility group box 1 (HMGB1) containing nuclear localization sequences (NLS). The HMGB1/branched or linear PEI (b-PEI or l-PEI) combined carriers have been investigated for their cytotoxicity and ability to condense and deliver plasmid DNA (pDNA) to mammalian cells in vitro. Both HMGB1 and PEI formed complexes with pDNA are revealed by a gel-retardation assay. Compared with pDNA/l-PEI complexes, a reduction in particle size was observed for pDNA/HMGB1/l-PEI ternary complexes. In MTT assay the results of cell viability suggested lower cytotoxicity for HMGB1/PEI combined carriers. Transfection efficiencies of pDNA/HMGB1/PEI ternary complexes were evaluated by green fluorescent protein expression level measured by fluorescence spectroscopy and flow cytometry. Transfection efficiencies for pDNA/HMGB1/l-PEI ternary complexes and pDNA/HMGB1/b-PEI ternary complexes showed more than 2.9-fold and 4.0-fold greater than that for pDNA/l-PEI complexes and pDNA/b-PEI complexes, respectively. Thus, our results showed that HMGB1/PEI combined carriers may be a versatile non-viral carrier for pDNA with high transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442462     DOI: 10.1016/j.ijpharm.2009.03.040

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Efficient intracellular gene delivery using the formulation composed of poly (L-glutamic acid) grafted polyethylenimine and histone.

Authors:  Jingjing Deng; Yuting Wen; Cuifeng Wang; Shirong Pan; Huaiyu Gu; Xin Zeng; Lina Han; Yuefang Zhao; Min Feng; Chuanbin Wu
Journal:  Pharm Res       Date:  2010-12-14       Impact factor: 4.200

Review 2.  Strategies on the nuclear-targeted delivery of genes.

Authors:  Jing Yao; Ying Fan; Yuanke Li; Leaf Huang
Journal:  J Drug Target       Date:  2013-08-22       Impact factor: 5.121

Review 3.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

4.  A novel disulfide bond-mediated cleavable RGD-modified PAMAM nanocomplex containing nuclear localization signal HMGB1 for enhancing gene transfection efficiency.

Authors:  Ji Li; Yuting Han; Yue Lu; Baohui Song; Ming Zhao; Haiyang Hu; Dawei Chen
Journal:  Int J Nanomedicine       Date:  2018-11-06

5.  The TFAMoplex-Conversion of the Mitochondrial Transcription Factor A into a DNA Transfection Agent.

Authors:  Michael Burger; Seraina Kaelin; Jean-Christophe Leroux
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.